Elwood & Goetz Wealth Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
1,965
+122
+7% +$14.3K 0.04% 134
2026
Q1
$222K Buy
+1,843
New +$213K 0.04% 132
2025
Q1
Sell
-3,410
Closed -$339K 103
2024
Q4
$339K Buy
3,410
+8
+0.2% +$825 0.08% 68
2024
Q3
$386K Hold
3,402
0.1% 64
2024
Q2
$421K Hold
3,402
0.12% 48
2024
Q1
$449K Buy
3,402
+400
+13% +$49.3K 0.11% 52
2023
Q4
$327K Buy
3,002
+122
+4% +$12.7K 0.07% 62
2023
Q3
$296K Buy
+2,880
New +$310K 0.07% 59

Other funds holding MRK

Elwood & Goetz Wealth Advisory Group's MRK Position: Q2 2026 in Review

Elwood & Goetz Wealth Advisory Group increased its Merck (MRK) stake by 6.6% in Q2 2026, buying an estimated $14.3K and bringing the position to 1,965 shares worth $253K. The position accounts for 0.04% of the portfolio, ranked #134.

Elwood & Goetz Wealth Advisory Group first reported a position in MRK in Q3 2023 and has held it in 8 quarters since. The position peaked at $449K in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Elwood & Goetz Wealth Advisory Group held 1,965 shares of Merck worth $253K as of Q2 2026.
  • Elwood & Goetz Wealth Advisory Group bought 122 Merck shares in Q2 2026, an estimated $14.3K.
  • Merck made up 0.04% of Elwood & Goetz Wealth Advisory Group's portfolio in Q2 2026, its #134 holding.
  • Elwood & Goetz Wealth Advisory Group first reported a position in Merck in Q3 2023 and has held it in 8 quarters since.
  • Elwood & Goetz Wealth Advisory Group's Merck position peaked at $449K in Q1 2024.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elwood & Goetz Wealth Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.